Brain Networks in Parkinson's Disease
Protocol ID
04-113T
Protocol Description
Dopamine is a chemical in the brain (called a neurotransmitter) that is involved in movement. In Parkinson’s disease, levels of this neurotransmitter are decreased in certain regions of the brain. The purpose of this study is to measure different types of brain function in patients with Parkinson’s disease and in normal volunteers. This will be done by taking brain scans that measure blood flow in the brain (cerebral blood flow), that measure how your brain uses energy (glucose metabolism), and that measure neurotransmitter (dopamine) levels.
Eligibility Criteria
Patients with Parkinson's disease and healthy controls
Primary Investigator(s)
- Michael Pourfar, MD